Blue Bell, PA (PRWEB) March 13, 2013
With over 30 million worldwide blog sites analyzed, the study provides fascinating insights into emotions by stage of cancer and emotions surrounding key drugs prescribed in head and neck, ovarian, breast, lung, colorectal, hepatocellular and renal cancers. It also identifies key opinion leaders(KOP’s) and influencers across the blogosphere.
In addition, the study has classified every Oncology drug mentioned across the blogosphere for its intensity of mention by category of disease. Key metrics such as emotions over time for competitive oncology drugs, emotions around treatment type (medication, radiation, surgery, etc.) as well as cohorts of physicians, patients, nurses and caregivers were analyzed. BehaviorMatrix presented findings around one of the disease categories studied, breast cancer, at the ePharma Summit.
“We have organized conversational unstructured Big Data around cancer and we intend to keep updating, monitoring and adding additional information to this semantic cancer warehouse including additional cancer areas, all new research and drugs during various stages of their clinical trials," stated William M. Thompson, BehaviorMatrix’s CEO.
About BehaviorMatrix, LLC: We have engineered the first behavioral analytics platform to analyze human emotion in digital conversation. Our technology allows us to gather and process huge quantities of unstructured Big Data (from a wide array of Digital Media sources) to analyze and quantify the emotion surrounding a brand, service, product or topic. The resulting information uncovers a wealth of actionable insights, allowing our clients to improve the effectiveness of their advertising, make intelligent strategic decisions, and improve customer relationships.
Learn and understand the Emotional Fingerprint℠, as well as Customer Experiential Perceptions℠ for your organization/brand and that of your competition. For more complete information, click here BehaviorMatrix